This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Nykode Therapeutics Asa. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Jeroen Van Bergen: Innovator in Immune-Stimulatory Compositions
Introduction
Jeroen Van Bergen is a notable inventor based in Leiden, Netherlands. He has made significant contributions to the field of immunology through his innovative work. His research focuses on developing compositions that stimulate immune responses, which can have profound implications for medical treatments.
Latest Patents
Jeroen holds a patent for "Immune-stimulatory compositions and use thereof." This invention relates to a constitutively active pro-inflammatory caspase, which comprises shuffled p10 and p20 domains. It is designed for use in methods that stimulate an immune response in individuals. The patent also includes an immune-stimulating composition that combines this caspase with a pharmacologically acceptable excipient, aimed at treating individuals effectively.
Career Highlights
Jeroen Van Bergen is associated with Nykode Therapeutics ASA, a company that focuses on developing innovative therapies. His work at Nykode Therapeutics has allowed him to explore the potential of immune-stimulatory compositions in various therapeutic applications. His dedication to advancing medical science is evident in his research and patent contributions.
Collaborations
Jeroen collaborates with Gerben Carolus Martinus Zondag, who is also involved in the field of immunology. Their partnership enhances the research efforts at Nykode Therapeutics, fostering innovation and development in immune therapies.
Conclusion
Jeroen Van Bergen's contributions to the field of immunology through his patent and work at Nykode Therapeutics highlight his role as an influential inventor. His innovative approaches to immune-stimulatory compositions pave the way for future advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile